SecBot SecBot
SECBOTREPLAY Home › Report › LYEL

LYEL · S-3 for 7.4M share resale

Lyell Immunopharma, Inc. · S-3 filed Nov 13, 2026 at 16:04 ET

At the news

NEUTRALIMPACT 3/10

S-3 filed Nov 13, 2026 at 16:04 ET

Lyell Immunopharma filed an S-3 registration statement to register 7,428,040 shares of common stock for resale by selling stockholders who acquired them in a private placement that closed on November 4, 2026 at $10.77 per share. The company will not receive any proceeds from the resale; the filing is a contractual obligation under the securities purchase agreement. The private placement raised $80M (stated in the prior earnings report) and extends the company's cash runway into 2028.

  • S-3 registers 7,428,040 shares of common stock for resale by selling stockholders
  • Shares were issued at $10.77 per share in a private placement that closed November 4, 2026
  • Company will not receive any proceeds from the resale
  • Maximum aggregate offering price calculated at $114,540,376.80 based on $15.42 reference price

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access